tiprankstipranks
Trending News
More News >
Eli Lilly & Co (LLY)
NYSE:LLY
US Market
Advertisement

Eli Lilly & Co (LLY) Drug Pipeline

Compare
18,999 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Abemaciclib, Letrozole, Anastrozole, Ribociclib, Palbociclib, Fulvestrant, Exemestane, Ly4064809
Breast Neoplasms, Neoplasm Metastasis
Phase III
Not Yet Recruiting
A Study of LY4064809 With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sep 12, 2025
Standard Of Care Antiemetic Therapies, Background Chemotherapy, Ly3537021
Neoplasms, Vomiting, Drug-Related Side Effects And Adverse Reactions, Nausea
Phase II
Not Yet Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Sep 05, 2025
Pirtobrutinib
Lymphoma, Non-Hodgkin, B-Cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell
Phase II
Recruiting
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
Aug 29, 2025
P-Tau217 Test
Alzheimer Disease
Phase III
Not Yet Recruiting
Epidemiology and Biomarker Study in Alzheimer's Disease
Aug 20, 2025
Ly3537982
Renal Insufficiency
Phase I
Not Yet Recruiting
A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function
Aug 17, 2025
Olomorasib
Healthy
Phase I
Not Yet Recruiting
A Study of Olomorasib (LY3537982) in Healthy Japanese Participants
Aug 13, 2025
Ly4256984
Als (Amyotrophic Lateral Sclerosis)
Phase I
Not Yet Recruiting
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Jul 31, 2025
LY4257496, Standard of Care Anticancer Therapies
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm, Endometrial Neoplasms, Neoplasm Metastasis
Phase I
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Jul 30, 2025
Ly4152199 - Iv, Ly4152199 - Sc
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell, B-Cell Lymphoma, Waldenstrom Macroglobulinemia, Lymphoma, Large B-Cell, Diffuse, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell Marginal Zone, Burkitt Lymphoma, Leukemia, B-Cell
Phase I
Not Yet Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Cancers and Leukemia
Jul 28, 2025
Ly3549492
Healthy
Phase II
Terminated
A Study of LY3549492 in Healthy Weight Adult Participants
Jul 18, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Eli Lilly & Co (LLY) have in its pipeline
      LLY is currently developing the following drugs: Abemaciclib, Letrozole, Anastrozole, Ribociclib, Palbociclib, Fulvestrant, Exemestane, Ly4064809, Standard Of Care Antiemetic Therapies, Background Chemotherapy, Ly3537021, Pirtobrutinib. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis